| |
Antibodies are a crucial reagent in R&D, diagnostics, & therapeutics. Download the eBook to learn how you can apply custom antibodies in your work.
|
|
Today's Big NewsDec 15, 2022 |
| By Eric Sagonowsky Horizon Therapeutics CEO Tim Walbert has made routine appearances in rankings of the biopharma industry's best-paid executives, and he's set to collect once again with his company's sale to Amgen. |
|
|
|
By Conor Hale After announcing that it had implanted its brain-computer interface in its first U.S. paralysis patient earlier this year, Synchron has raised $75 million to take its mind-reading tech to the next level. |
By James Waldron Sio Gene Therapies has kept its head down since dropping its final two assets and most staff in April, but the company has finally confirmed that it’s shutting up shop for good. |
By Paige Minemyer Health spending grew by 2.7% in 2021, reaching $4.3 trillion, according to new data from the Centers for Medicare & Medicaid Services. |
|
If the clinical supply chain is poorly managed, sponsors can struggle to cope with the complexities, causing issues. This playbook covers keys to identifying the need to implement an eClinical Supply Chain Management platform. Download now.
|
|
By Dave Muoio Hospitals added a net 11,000 jobs to their payrolls in November, but a hiring slowdown, low unemployment, lingering high quit rates and an uptick in respiratory illnesses all threaten continued gains. |
By Kevin Dunleavy The FDA has delayed its target date for its decision on AstraZeneca and Merck's Lynparza in metastatic castration-resistant prostate cancer (mCRPC). The agency has pushed back the decision date by three months to “provide further time for the full review of the submission,” Merck said. |
By Conor Hale Limited to four tests per household, the potential stocking stuffers will begin shipping through the mail December 19. |
By Annalee Armstrong Last month, BioCryst trimmed down its pipeline to two drugs in complement-mediated diseases: BCX9930 and BCX10013. Fast forward 45 days and BCX9930 is headed to the garbage can, too. |
By Dave Muoio Two-thirds of the 53 rural hospital closures reviewed by researchers occurred within the Southern U.S. with just over a fifth located in Appalachia. Shutdowns were associated with significant increases in average emergency department and inpatient volumes among surrounding facilities. |
By James Waldron Axcella is reducing its workforce by 85% as it drops its nonalcoholic fatty liver disease program and focuses its remaining resources on its long COVID candidate. |
By Zoey Becker The Interfaith Center on Corporate Responsibility, a group of activist stakeholders, asked top drugmakers to consider patient access when they develop patent strategies. |
By Sharon Klahr Coey The relationship between art, beauty and self-expression is a close one. Galderma continues to foster those ties as the exclusive aesthetic injectables sponsor of Scope Miami Beach, a showcase for emerging contemporary art. |
Fierce podcastsDon't miss an episode |
| This week on “The Top Line,” we discuss the latest from the Clinical Trials on Alzheimer’s Disease conference. Plus, we cover the week's news including an investigation into Neuralink, Google’s DeepMind and why things aren't working out for PI3Ks. |
|
|---|
|
|
|
Wednesday, January 25, 2023 | 11am ET / 8am PT This webinar, presented by AmerisourceBergen, will deliver insights to manufacturers and payers covering the need for education and best practices for increasing biosimilar adoption, current product landscape and upcoming product launches, and more. Register now.
|
|
| VideoRevolutionize your monoclonal antibody (mAb) manufacturing with expert insights. Sponsored by: Gibco |
| WhitepaperLearn how to develop a high-performing supply chain for GMP-manufactured chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific. Sponsored by: Thermo Fisher Scientific |
| WhitepaperPreparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
| Webinar Twist Bioscience CSO Dr. Aaron Sato shares how Twist's tools for antibody discovery have been applied to identify antibodies against diverse and challenging targets. See how high-throughput DNA synthesis combined with antibody engineering expertise provides end-to-end antibody discovery solutions. Presented by: Twist Bioscience |
| Executive Summary Strategies to help scale-up for commercial manufacturing are critical to getting cell and gene therapies to patients as more advanced therapies reach late-stage clinical studies and regulatory decisions. Sponsored by: Catalent |
| WhitepaperHow can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent |
| Whitepaper Download this paper to learn considerations on how to move a biologic through clinical trials faster, advantages of Parallel Processing, and more. Sponsored by: Catalent |
| WhitepaperWhat are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored By: Catalent |
| WhitepaperLearn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Biologics |
| Research Learn more on an approach for process characterization for the production of a monoclonal antibody, which will improve the efficiency and effectiveness of the process by targeting the right design and number of experiments. Sponsored by: Catalent |
| WhitepaperExplore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| |
|
